OOIR: Observatory of International Research

Papers

(The TQCC of Personalized Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension	65
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients	29
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness	22
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population	17
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia	16
An evidence gap map of the personalized medicine in bladder cancer	15
Pharmacogenomics education in China and the United States: advancing personalized medicine	14
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing	12
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis	10
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease	9
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls	9
Precision acute medical care through “-omic” analyses: a scoping review	8
Personalized approach in arrhythmology by genetic-based data: a case report	8
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer	8
Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis	7
Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models	6
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?	6
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation	6
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?	6
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study	6
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites	6
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis	6
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar	5
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups	5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries	5

Welcome to the 19th Volume of Personalized Medicine	5
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam	5
Looking Back Over 2023 and Welcome to the 21 ^st Issue of Personalized Medicine	5
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children	5
Role of precision nutrition in improving military performance	5
Development of Competency-based Online Genomic Medicine Training (COGENT)	5
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK	4
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head	4
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System	4
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population	4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead	4
Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes	4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation	4
Genomics and the early diagnosis of lung cancer	4
Regional disparities in access to gene therapies in the European Union, the United States, Japan, and China	4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device	4
Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan	3
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients	3
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients	3
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment	3
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young	3
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations	3
Association of miR-21 rs1292037 polymorphism with congenital heart disease susceptibility in Chinese children	3
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation	3
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus	3
Global harmonization in advanced therapeutics: balancing innovation, safety, and access	3
The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis	3
A rare likely pathogenic HLA-DRB1 variant with compromised immunity in severe COVID-19 patient and in-hospital mortality	3
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines	3
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine	3
The United States 2020 Census Data: Implications for Precision Medicine and the Research Landscape	3
Development of a computer-based tool to obtain a family health history in Vietnam	3
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety	3
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice	3